ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,434Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 972

$518K Total Retail Price of All Prescriptions

Rank: 298 out of 972

598 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 598 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 598 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 11,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 724 718 1 2
LEVOTHYROXINE SODIUM 706 661 2 3
LISINOPRIL 604 567 3 1
AMLODIPINE BESYLATE 454 418 4 4
HYDROCODONE-ACETAMINOPHEN 426 286 S3 5 6
METOPROLOL TARTRATE 354 291 6 9
OMEPRAZOLE 336 257 7 5
METOPROLOL SUCCINATE 298 268 8 16
METFORMIN HCL 270 231 9 8
FUROSEMIDE 270 256 9 7
ZOLPIDEM TARTRATE 259 209 11 23
POTASSIUM CHLORIDE 252 244 12 13
HYDROCHLOROTHIAZIDE 195 187 13 10
CITALOPRAM HBR 191 182 14 19
PRAVASTATIN SODIUM 187 169 15 20
WARFARIN SODIUM 143 141 16 12
ALLOPURINOL 142 138 17 28
TRAMADOL HCL 139 120 18 15
SERTRALINE HCL 138 117 19 25
ATORVASTATIN CALCIUM 137 130 20 11
AZITHROMYCIN 136 112 21 42
FLUTICASONE PROPIONATE 136 120 21 31
LOSARTAN POTASSIUM 134 128 23 17
GABAPENTIN 133 130 24 14
LOVASTATIN 129 115 25 22
NEXIUM 125 90 26 30
ATENOLOL 121 113 27 18
BENAZEPRIL HCL 117 117 28 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 94 29 32
CARVEDILOL 115 114 29 21
DIOVAN 110 97 31 48
ALPRAZOLAM 89 51 32 288
SPIRONOLACTONE 87 78 33 54
GLYBURIDE 86 86 R 34 70
ALENDRONATE SODIUM 86 77 34 27
SYNTHROID 86 70 34 51
GLIPIZIDE ER 83 72 37 103
ADVAIR DISKUS 81 58 38 45
TRIAMTERENE-HCTZ 74 55 39 39
DONEPEZIL HCL 73 73 40 26
ESTRADIOL 71 52 R 41 167
DOXAZOSIN MESYLATE 70 61 42 82
CIPROFLOXACIN HCL 70 59 42 63
PAROXETINE HCL 68 60 44 64
AMITRIPTYLINE HCL 67 48 R 45 58
TAMSULOSIN HCL 66 66 46 29
PROAIR HFA 65 59 47 47
TORSEMIDE 64 64 48 131
LANSOPRAZOLE 63 58 49 210
DICLOFENAC SODIUM 62 55 50 130
CLONIDINE HCL 61 61 51 57
DILTIAZEM 24HR CD 58 51 52 74
FENOFIBRATE 56 24 53 66
DIGOXIN 56 56 53 52
GLIPIZIDE XL 55 51 55 198
VERAPAMIL ER 54 48 56 108
NAPROXEN 54 39 56 71
AMLODIPINE BESYLATE-BENAZEPRIL 52 45 58 114
DILTIAZEM ER 52 38 58 129
CEFDINIR 52 48 58 187
CYCLOBENZAPRINE HCL 52 14 R 58 53
CYMBALTA 51 30 62 49
COMBIVENT 51 25 62 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.